Neoadjuvant therapy for early-stage breast cancer: the clinical utility of pertuzumab

Approximately 20% of breast cancer patients harbor tumors that overexpress human epidermal growth factor receptor 2 (HER2; also known as ErbB2), a receptor tyrosine kinase that belongs to the epidermal growth factor receptor family of receptor tyrosine kinases. HER2 amplification and hyperactivation...

Descripción completa

Detalles Bibliográficos
Autores principales: Gollamudi, Jahnavi, Parvani, Jenny G, Schiemann, William P, Vinayak, Shaveta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4762586/
https://www.ncbi.nlm.nih.gov/pubmed/26937204
http://dx.doi.org/10.2147/CMAR.S55279

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4762586/
https://www.ncbi.nlm.nih.gov/pubmed/26937204
http://dx.doi.org/10.2147/CMAR.S55279

Ejemplares similares